APA (7th ed.) Citation

T, K., H, N., K, F., K, B., K, M., S, Y., . . . T, S. (2023). Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo. The Journal of antimicrobial chemotherapy, 78(4), 946. https://doi.org/10.1093/jac/dkad027

Chicago Style (17th ed.) Citation

T, Kuroda, et al. "Efficacy Comparison of 3CL Protease Inhibitors Ensitrelvir and Nirmatrelvir Against SARS-CoV-2 in Vitro and in Vivo." The Journal of Antimicrobial Chemotherapy 78, no. 4 (2023): 946. https://doi.org/10.1093/jac/dkad027.

MLA (9th ed.) Citation

T, Kuroda, et al. "Efficacy Comparison of 3CL Protease Inhibitors Ensitrelvir and Nirmatrelvir Against SARS-CoV-2 in Vitro and in Vivo." The Journal of Antimicrobial Chemotherapy, vol. 78, no. 4, 2023, p. 946, https://doi.org/10.1093/jac/dkad027.